Alliancebernstein L.P. Has $193.45 Million Position in Encompass Health Corporation $EHC

Key Points

• Alliancebernstein L.P. reduced its stake in Encompass Health Corporation by 8.0% in the first quarter, holding approximately 1.89% of the company worth about $193.4 million after selling 166,831 shares.
• Encompass Health has announced a quarterly dividend increase to $0.19 per share, set to be paid on October 15th, leading to an annualized yield of 0.6%.
• Analysts have upgraded their target prices for Encompass Health, with revisions from $130.00 to $140.00, signaling positive outlooks for the stock's performance.

Alliancebernstein L.P. reduced its stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 8.0% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 1,910,038 shares of the company's stock after selling 166,831 shares during the period. Alliancebernstein L.P. owned approximately 1.89% of Encompass Health worth $193,449,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the stock. AlTi Global Inc. acquired a new stake in Encompass Health during the 1st quarter worth approximately $1,908,000. Adage Capital Partners GP L.L.C. raised its holdings in Encompass Health by 11.5% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 205,162 shares of the company's stock worth $20,779,000 after buying an additional 21,100 shares during the period. Dark Forest Capital Management LP raised its holdings in Encompass Health by 611.6% during the 1st quarter. Dark Forest Capital Management LP now owns 51,981 shares of the company's stock worth $5,265,000 after buying an additional 44,676 shares during the period. EP Wealth Advisors LLC raised its holdings in Encompass Health by 10.7% during the 1st quarter. EP Wealth Advisors LLC now owns 3,606 shares of the company's stock worth $365,000 after buying an additional 349 shares during the period. Finally, Royal Bank of Canada raised its holdings in Encompass Health by 21.5% during the 1st quarter. Royal Bank of Canada now owns 88,470 shares of the company's stock worth $8,960,000 after buying an additional 15,677 shares during the period. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the company's stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total value of $126,061.80. Following the transaction, the executive vice president directly owned 18,846 shares in the company, valued at $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 2.10% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several analysts have commented on EHC shares. Truist Financial raised their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a report on Thursday, August 14th. Bank of America lifted their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the company a "buy" rating in a report on Wednesday. UBS Group lifted their price objective on shares of Encompass Health from $130.00 to $140.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Stephens upgraded shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective on the stock in a report on Thursday, June 5th. Finally, KeyCorp lifted their price objective on shares of Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a report on Tuesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating and seven have given a Buy rating to the company. According to MarketBeat.com, Encompass Health currently has an average rating of "Buy" and an average price target of $137.71.

Encompass Health Stock Down 0.4%

Shares of NYSE:EHC traded down $0.54 during midday trading on Wednesday, hitting $124.76. The stock had a trading volume of 99,265 shares, compared to its average volume of 804,747. Encompass Health Corporation has a 12 month low of $87.85 and a 12 month high of $126.49. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The business's 50-day simple moving average is $117.09 and its 200-day simple moving average is $112.30. The company has a market cap of $12.57 billion, a P/E ratio of 24.41, a PEG ratio of 2.20 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.20 by $0.20. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The business had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.43 billion. During the same period last year, the business earned $1.11 earnings per share. The firm's revenue was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. On average, sell-side analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a $0.19 dividend. This is an increase from Encompass Health's previous quarterly dividend of $0.17. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Wednesday, October 1st. Encompass Health's dividend payout ratio is presently 14.87%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.